OVARIAN CANCER and US: brain

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label brain. Show all posts
Showing posts with label brain. Show all posts

Wednesday, February 29, 2012

Canadian Scientists Develops World’s Most Advanced Drug to Protect the Brain After a Stroke (PSD95 inhibitor)



“There is hope that this new drug could be used in conjunction with other treatments, such as thrombolytic agents or other means to restore blood flow to the brain, in order to further reduce the impact of stroke on patients,” said Dr. Tymianski. “These findings are extremely exciting and our next step is to confirm these results in a clinical trial.”

Wednesday, March 30, 2011

Lynch Syndrome Hereditary Cancers Public Awareness Day | Fight Colorectal Cancer



Increased Risk of Cancer

If a parent carries a Lynch mutation there is a 50-50 chance that their child will inherit Lynch syndrome with
  • 60 to 80 percent increased lifetime risk of colorectal cancer.
  • 40 to 70 percent increased risk of endometrial cancer (cancer of the uterus lining).
  • 13 percent increased risk for stomach cancer
  • 12 percent increased risk of ovarian cancer.
  • smaller, but significant risk of small intestine, urinary tract, heptobiliary (liver, gall bladder and bile ducts), skin, and brain cancers.
  • Some families may also have increased risk for breast cancer.
Note: 
Lynch Syndrome is also noted for multiple primary cancers (different cancers in one person)





Wednesday, July 21, 2010

Monday, May 10, 2010

full access: PLoS ONE: Ovarian Cyst Fluid of Serous Ovarian Tumors Contains Large Quantities of the Brain Amino Acid N-acetylaspartate



Background

"In humans, N-acetyl L-aspartate (NAA) has not been detected in other tissues than the brain. The physiological function of NAA is yet undefined. Recently, it has been suggested that NAA may function as a molecular water pump, responsible for the removal of large amounts of water from the human brain. Ovarian tumors typically present as large cystic masses with considerable fluid accumulation....."

Thursday, December 24, 2009

open access: Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management



Subjects carrying a mutation in one of the MMR genes have a higher risk for developing colorectal cancer, but also for endometrial carcinoma and malignancies of the stomach, small bowel, ovaries, upper uroepithelial tract, biliary tract, skin and brain.(pancreas)